The Niche

Business round-up: pluripotent products, all-star academics and headlines everywhere

Academic all-stars from the East and West Coasts of the US have united to advise a company with plans to use induced pluripotent stem (iPS) cells to find drugs. The company, created from the merger of Boston-based Perian and San Francisco-based iZumi, will be called iPierian and run by iZumi CEO John Walker from San Francisco. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE